Found: 102
Select item for more details and to access through your institution.
Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatment.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae054
- By:
- Publication type:
- Article
Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 1, p. 1, doi. 10.1093/rap/rkae002
- By:
- Publication type:
- Article
Jaw claudication and jaw stiffness in giant cell arteritis: secondary analysis of a qualitative research dataset.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 1, p. 1, doi. 10.1093/rap/rkad082
- By:
- Publication type:
- Article
Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank.
- Published in:
- Rheumatology Advances in Practice, 2023, v. 7, n. 3, p. 1, doi. 10.1093/rap/rkad095
- By:
- Publication type:
- Article
Benchmarking tocilizumab use for giant cell arteritis.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac037
- By:
- Publication type:
- Article
Curry-assisted diagnosis in the rheumatology clinic.
- Published in:
- Oxford Medical Case Reports, 2015, v. 2015, n. 6, p. 297, doi. 10.1093/omcr/omv040
- By:
- Publication type:
- Article
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis--results from the IDEA study.
- Published in:
- Rheumatology, 2016, v. 55, n. 12, p. 2181, doi. 10.1093/rheumatology/kew306
- By:
- Publication type:
- Article
Increase in admissions related to giant cell arteritis and polymyalgia rheumatica in the UK, 2002–13, without a decrease in associated sight loss: potential implications for service provision.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Increase in admissions related to giant cell arteritis and polymyalgia rheumatica in the UK, 2002–13, without a decrease in associated sight loss: potential implications for service provision.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis.
- Published in:
- Rheumatology, 2015, v. 54, n. 2, p. 359, doi. 10.1093/rheumatology/keu321
- By:
- Publication type:
- Article
P14. Investigations prior to temporal artery biopsy: a retrospective audit of compliance with the British Society for Rheumatology Guidelines for giant cell arteritis.
- Published in:
- Rheumatology, 2014, v. 53, n. suppl_2, p. i17, doi. 10.1093/rheumatology/keu185
- By:
- Publication type:
- Article
18. Challenges in developing clinical practice guidelines for diagnostic tests: a systematic literature review of the use of imaging for the diagnosis of polymyalgia rheumatica.
- Published in:
- Rheumatology, 2014, v. 53, n. suppl_2, p. i10, doi. 10.1093/rheumatology/keu203
- By:
- Publication type:
- Article
18. Challenges in developing clinical practice guidelines for diagnostic tests: a systematic literature review of the use of imaging for the diagnosis of polymyalgia rheumatica.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
P14. Investigations prior to temporal artery biopsy: a retrospective audit of compliance with the British Society for Rheumatology Guidelines for giant cell arteritis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Comment on: Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors: reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors.
- Published in:
- Rheumatology, 2011, v. 50, n. 11, p. 2014, doi. 10.1093/rheumatology/ker265
- By:
- Publication type:
- Article
Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study.
- Published in:
- Rheumatology, 2010, v. 49, n. 4, p. 716, doi. 10.1093/rheumatology/kep395
- By:
- Publication type:
- Article
Polymyalgia rheumatica: pathogenesis and management.
- Published in:
- Clinical Medicine, 2013, v. 13, n. 4, p. 398, doi. 10.7861/clinmedicine.13-4-398
- By:
- Publication type:
- Article
Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2307, doi. 10.1093/rheumatology/kead643
- By:
- Publication type:
- Article
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2259, doi. 10.1093/rheumatology/kead569
- By:
- Publication type:
- Article
Genetically proxied IL-1 receptor antagonism and risk of polymyalgia rheumatica.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. e43, doi. 10.1093/rheumatology/kead423
- By:
- Publication type:
- Article
Validation of a patient-reported outcome measure for giant cell arteritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 181, doi. 10.1093/rheumatology/kead201
- By:
- Publication type:
- Article
Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3710, doi. 10.1093/rheumatology/kead179
- By:
- Publication type:
- Article
Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3565, doi. 10.1093/rheumatology/kead081
- By:
- Publication type:
- Article
Quality standards for the care of people with giant cell arteritis in secondary care.
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. 3075, doi. 10.1093/rheumatology/kead025
- By:
- Publication type:
- Article
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2797, doi. 10.1093/rheumatology/keac713
- By:
- Publication type:
- Article
Angiotensin receptor blockade is associated with increased risk of giant cell arteritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2203, doi. 10.1093/rheumatology/keac599
- By:
- Publication type:
- Article
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4671, doi. 10.1093/rheumatology/keab076
- By:
- Publication type:
- Article
Ensuring high standards of British Society for Rheumatology clinical guidelines: reflections from the coalface.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Why clinicians should know about Mendelian randomization.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
What can negative temporal artery biopsies tell us?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 487, doi. 10.1093/rheumatology/kez664
- By:
- Publication type:
- Article
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. e1, doi. 10.1093/rheumatology/kez672
- By:
- Publication type:
- Article
Temporal artery biopsy: audit of histological diagnosis.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 678, doi. 10.1093/rheumatology/kez396
- By:
- Publication type:
- Article
Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study.
- Published in:
- Rheumatology, 2020, v. 59, n. 2, p. 319, doi. 10.1093/rheumatology/kez289
- By:
- Publication type:
- Article
Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 9, p. 1684, doi. 10.1093/rheumatology/kez114
- By:
- Publication type:
- Article
Giant cell arteritis: new concepts, treatments and the unmet need that remains.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Giant cell arteritis: new concepts, treatments and the unmet need that remains.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
216 Characteristics of patients with prevalent giant cell arteritis in UK primary care.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
217 Results of a patient survey on feasibility and face validity of outcome measures for intended use in future studies enrolling participants with polymyalgia rheumatica.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
010 Temporal artery biopsy: audit, scoring and reporting.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
267. Patient perceptions of health related quality of life related to giant cell arteritis and its treatment: an international qualitative study.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
102. Proposal for a synoptic system for reporting of temporal artery biopsies.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Achieving consensus on minimum data items (including core outcome domains) for a longitudinal observational cohort study in rheumatoid arthritis.
- Published in:
- Rheumatology, 2017, v. 56, n. 4, p. 550, doi. 10.1093/rheumatology/kew416
- By:
- Publication type:
- Article